RU2000111489A - ANTIPSYCHOTIC SUBSTITUTED PIPERIDINE DERIVATIVES - Google Patents
ANTIPSYCHOTIC SUBSTITUTED PIPERIDINE DERIVATIVESInfo
- Publication number
- RU2000111489A RU2000111489A RU2000111489/04A RU2000111489A RU2000111489A RU 2000111489 A RU2000111489 A RU 2000111489A RU 2000111489/04 A RU2000111489/04 A RU 2000111489/04A RU 2000111489 A RU2000111489 A RU 2000111489A RU 2000111489 A RU2000111489 A RU 2000111489A
- Authority
- RU
- Russia
- Prior art keywords
- alkyl
- aryl
- pharmaceutically acceptable
- cycloalkyl
- formula
- Prior art date
Links
- 230000000561 anti-psychotic Effects 0.000 title 1
- 150000003053 piperidines Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 claims 18
- 150000001875 compounds Chemical class 0.000 claims 18
- 150000003839 salts Chemical class 0.000 claims 13
- 239000011780 sodium chloride Substances 0.000 claims 13
- 239000012453 solvate Substances 0.000 claims 12
- 125000001424 substituent group Chemical group 0.000 claims 12
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 10
- 229910052736 halogen Inorganic materials 0.000 claims 9
- 125000001544 thienyl group Chemical group 0.000 claims 8
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 7
- 150000002367 halogens Chemical class 0.000 claims 7
- -1 C 1-6 -alkyl Chemical group 0.000 claims 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 6
- 125000005418 aryl aryl group Chemical group 0.000 claims 5
- 125000003118 aryl group Chemical group 0.000 claims 5
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims 4
- 125000000623 heterocyclic group Chemical group 0.000 claims 4
- 229910052739 hydrogen Inorganic materials 0.000 claims 4
- 239000001257 hydrogen Substances 0.000 claims 4
- 125000003545 alkoxy group Chemical group 0.000 claims 3
- 125000005843 halogen group Chemical group 0.000 claims 3
- 125000001072 heteroaryl group Chemical group 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- 150000002829 nitrogen Chemical group 0.000 claims 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 2
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims 2
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims 2
- 125000002541 furyl group Chemical group 0.000 claims 2
- 150000002431 hydrogen Chemical class 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 230000003993 interaction Effects 0.000 claims 2
- 125000001624 naphthyl group Chemical group 0.000 claims 2
- GKMYFUVAUFPJMP-UHFFFAOYSA-N (2,2-dimethylazetidin-1-yl)-[3-[[4-[(4-fluorophenyl)-(4-methylthiophen-2-yl)methylidene]piperidin-1-yl]methyl]phenyl]methanone Chemical compound CC1=CSC(C(=C2CCN(CC=3C=C(C=CC=3)C(=O)N3C(CC3)(C)C)CC2)C=2C=CC(F)=CC=2)=C1 GKMYFUVAUFPJMP-UHFFFAOYSA-N 0.000 claims 1
- 125000001963 4 membered heterocyclic group Chemical group 0.000 claims 1
- OQNFYNDAOMBLDB-UHFFFAOYSA-N 4-[4-[(3-fluorophenyl)-(4-methylthiophen-2-yl)methylidene]piperidin-1-yl]-1-piperidin-1-ylbutan-1-one Chemical compound CC1=CSC(C(=C2CCN(CCCC(=O)N3CCCCC3)CC2)C=2C=C(F)C=CC=2)=C1 OQNFYNDAOMBLDB-UHFFFAOYSA-N 0.000 claims 1
- KYWBPNJQEQFTOU-UHFFFAOYSA-N 4-[4-[(4-fluorophenyl)-(4-methylthiophen-2-yl)methylidene]piperidin-1-yl]-1-piperidin-1-ylbutan-1-one Chemical compound CC1=CSC(C(=C2CCN(CCCC(=O)N3CCCCC3)CC2)C=2C=CC(F)=CC=2)=C1 KYWBPNJQEQFTOU-UHFFFAOYSA-N 0.000 claims 1
- IVRXYNGCLVFEPJ-UHFFFAOYSA-N 4-[4-[(4-fluorophenyl)-(4-methylthiophen-2-yl)methylidene]piperidin-1-yl]-1-pyrrolidin-1-ylbutan-1-one Chemical compound CC1=CSC(C(=C2CCN(CCCC(=O)N3CCCC3)CC2)C=2C=CC(F)=CC=2)=C1 IVRXYNGCLVFEPJ-UHFFFAOYSA-N 0.000 claims 1
- 125000002373 5 membered heterocyclic group Chemical group 0.000 claims 1
- 125000004070 6 membered heterocyclic group Chemical group 0.000 claims 1
- NMVBXLLLAYJUIS-UHFFFAOYSA-N [3-[[4-[(4-ethylthiophen-2-yl)-(4-fluorophenyl)methylidene]piperidin-1-yl]methyl]phenyl]-piperidin-1-ylmethanone Chemical compound CCC1=CSC(C(=C2CCN(CC=3C=C(C=CC=3)C(=O)N3CCCCC3)CC2)C=2C=CC(F)=CC=2)=C1 NMVBXLLLAYJUIS-UHFFFAOYSA-N 0.000 claims 1
- KXTXKFAHQRWCFW-UHFFFAOYSA-N [3-[[4-[(4-ethylthiophen-2-yl)-(4-fluorophenyl)methylidene]piperidin-1-yl]methyl]phenyl]-pyrrolidin-1-ylmethanone Chemical compound CCC1=CSC(C(=C2CCN(CC=3C=C(C=CC=3)C(=O)N3CCCC3)CC2)C=2C=CC(F)=CC=2)=C1 KXTXKFAHQRWCFW-UHFFFAOYSA-N 0.000 claims 1
- KMHASFKPNAYSMP-UHFFFAOYSA-N [3-[[4-[(4-fluorophenyl)-(4-methylthiophen-2-yl)methylidene]piperidin-1-yl]methyl]phenyl]-piperidin-1-ylmethanone Chemical compound CC1=CSC(C(=C2CCN(CC=3C=C(C=CC=3)C(=O)N3CCCCC3)CC2)C=2C=CC(F)=CC=2)=C1 KMHASFKPNAYSMP-UHFFFAOYSA-N 0.000 claims 1
- OXTRPAXZBSYCNI-UHFFFAOYSA-N [3-[[4-[(4-fluorophenyl)-(4-methylthiophen-2-yl)methylidene]piperidin-1-yl]methyl]phenyl]-pyrrolidin-1-ylmethanone;hydrochloride Chemical compound Cl.CC1=CSC(C(=C2CCN(CC=3C=C(C=CC=3)C(=O)N3CCCC3)CC2)C=2C=CC(F)=CC=2)=C1 OXTRPAXZBSYCNI-UHFFFAOYSA-N 0.000 claims 1
- FOGBQJGGWRTHIR-UHFFFAOYSA-N [3-[[4-[1-benzothiophen-2-yl-(4-fluorophenyl)methylidene]piperidin-1-yl]methyl]phenyl]-piperidin-1-ylmethanone Chemical compound C1=CC(F)=CC=C1C(C=1SC2=CC=CC=C2C=1)=C1CCN(CC=2C=C(C=CC=2)C(=O)N2CCCCC2)CC1 FOGBQJGGWRTHIR-UHFFFAOYSA-N 0.000 claims 1
- LMIKDBAZIJIQMQ-UHFFFAOYSA-N [3-[[4-[1-benzothiophen-2-yl-(4-fluorophenyl)methylidene]piperidin-1-yl]methyl]phenyl]-pyrrolidin-1-ylmethanone Chemical compound C1=CC(F)=CC=C1C(C=1SC2=CC=CC=C2C=1)=C1CCN(CC=2C=C(C=CC=2)C(=O)N2CCCC2)CC1 LMIKDBAZIJIQMQ-UHFFFAOYSA-N 0.000 claims 1
- 125000002877 alkyl aryl group Chemical group 0.000 claims 1
- 150000001412 amines Chemical class 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N fumaric acid Chemical compound OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 1
- VZCYOOQTPOCHFL-UPHRSURJSA-L maleate(2-) Chemical compound [O-]C(=O)\C=C/C([O-])=O VZCYOOQTPOCHFL-UPHRSURJSA-L 0.000 claims 1
- ZIYVHBGGAOATLY-UHFFFAOYSA-L methylmalonate(2-) Chemical compound [O-]C(=O)C(C)C([O-])=O ZIYVHBGGAOATLY-UHFFFAOYSA-L 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 238000000844 transformation Methods 0.000 claims 1
- 230000001131 transforming Effects 0.000 claims 1
Claims (10)
где R1 обозначает бензотиенил, бензофуранил, нафтил (где эта бензотиенильная, бензофуранильная или нафтильная часть молекулы может быть необязательно замещена одним или несколькими заместителями, выбранными из галогена, C1-6-алкила, С3-6-циклоалкила, C1-6-алкокси и С2-6-алкенила), замещенный тиенил или замещенный фуранил (где эта тиенильная или фуранильная часть молекулы замещена одним или несколькими заместителями, выбранными из галогена, C1-6-алкила, С3-6-алкила, C1-6-алкокси и С2-6-алкенила),
R2 обозначает замещенный фенил или замещенный тиенил (где эта фенильная или тиенильная часть молекулы замещена одним или несколькими заместителями, выбранными из C1-6-алкила и галогена);
R3 обозначает - (CH2)mXCONR4R5 или - (СН2)mNR6OR7, где R4 обозначает водород или C1-6-алкил и R5 обозначает водород, C1-6-алкил, С3-6-циклоалкил, С6-12-арил, С6-12-арил-С1-6-алкил или С3-9-гетероциклическую группу (где эта алкильная, арильная или гетероарильная часть молекулы может быть необязательно замещена одним или несколькими заместителями, выбранными из галогена, C1-6-алкила, С3-6-циклоалкила, C1-6-алкокси и С2-6-алкенила), или R4 и R5 вместе с атомом азота, к которому они присоединены, образуют 4-10-членную гетероциклическую группу (необязательно замещенную одним или несколькими заместителями, выбранными из галогена, C1-6-алкила, С3-6-циклоалкила, C1-6-алкокси и С2-6-алкенила), R6 обозначает водород или C1-6-алкил, R7 обозначает С3-6-циклоалкил, С3-6-циклоалкил-С1-6-алкил, С6-12-арил, С6-12-арил-С1-6-алкил или С3-9-гетероциклическую группу (где эта алкильная, арильная гетероциклическая часть молекулы может быть необязательно замещена одним или несколькими заместителями, выбранными из галогена, C1-6-алкила, С3-6-циклоалкила, C1-6-алкокси и С2-6-алкенила), Х обозначает связь, C6-12-арил или 5- или 6-членный гетероарил (где эта арильная или гетероарильная часть молекулы необязательно замещена одним или несколькими заместителями, выбранными из галогена, C1-6-алкила, С3-6-циклоалкила, C1-6-алкокси и С2-6-алкенила); где m обозначает целое число 1, 2, 3 или 4; или их фармацевтически приемлемую соль или сольват.1. The compound of formula (I)
where R 1 is benzothienyl, benzofuranyl, naphthyl (where this benzothienyl, benzofuranyl or naphthyl moiety may optionally be substituted with one or more substituents selected from halogen, C 1-6 alkyl, C 3-6 cycloalkyl, C 1-6 -alkoxy and C 2-6 alkenyl), substituted thienyl or substituted furanyl (where this thienyl or furanyl part of the molecule is substituted by one or more substituents selected from halogen, C 1-6 alkyl, C 3-6 alkyl, C 1 -6- alkoxy and C 2-6 -alkenyl),
R 2 is substituted phenyl or substituted thienyl (where this phenyl or thienyl moiety is substituted with one or more substituents selected from C 1-6 alkyl and halogen);
R 3 is - (CH 2 ) m XCONR 4 R 5 or - (CH 2 ) m NR 6 OR 7 , where R 4 is hydrogen or C 1-6 alkyl and R 5 is hydrogen, C 1-6 alkyl, C 3-6 cycloalkyl, C 6-12 aryl, C 6-12 aryl-C 1-6 alkyl or a C 3-9 heterocyclic group (where this alkyl, aryl or heteroaryl part of the molecule may optionally be substituted with one or several substituents selected from halogen, C 1-6 alkyl, C 3-6 cycloalkyl, C 1-6 alkoxy and C 2-6 alkenyl), or R 4 and R 5 together with a nitrogen atom to which they are attached to form a 4-10 membered heterocyclic group (optionally substituted nnuyu one or more substituents selected from halo, C 1-6 -alkyl, C 3-6 -cycloalkyl, C 1-6 -alkoxy and C 2-6 -alkenyl), R 6 represents hydrogen or C 1-6 alkyl , R 7 is C 3-6 cycloalkyl, C 3-6 cycloalkyl-C 1-6 alkyl, C 6-12 aryl, C 6-12 aryl-C 1-6 alkyl or C 3-9 a heterocyclic group (where this alkyl, aryl heterocyclic part of the molecule may be optionally substituted with one or more substituents selected from halogen, C 1-6 alkyl, C 3-6 cycloalkyl, C 1-6 alkoxy and C 2-6 -alkenyl), X is a bond, C 6-12 aryl or 5- or 6-membered heteroaryl (where this aryl or heteroaryl part of the molecule is optionally substituted with one or more substituents selected from halogen, C 1-6 alkyl, C 3-6 cycloalkyl, C 1-6 alkoxy and C 2-6 alkenyl); where m is an integer of 1, 2, 3 or 4; or a pharmaceutically acceptable salt or solvate thereof.
1-[4-[4-[(4-фторфенил)(4-метилтиен-2-ил)метилен] пиперидин-1-ил] -1-оксобутил] -пиперидин (1: 1) этандикарбоксилата,
1-[4-[4-[(4-фторфенил)(4-метилтиен-2-ил)метилен] пиперидин-1-ил] -1-оксобутил] -пирролидина, дигидрохлорида,
1-[4-[4-[(3-фторфенил)(4-метилтиен-2-ил)метилен] пиперидин-1-ил] -1-оксобутил] -пиперидина, гидрохлорида,
1-[3-[4-[(4-фторфенил)(4-метилтиен-2-ил)метилен] пиперидин-1-илметил] бензоил] пиперидина,
1-[3-[4-[(4-фторфенил)(4-метилтиен-2-ил)метилен] пиперидин-1-илметил] бензоил] пирролидина, гидрохлорида,
1-[3-[4-[(4-фторфенил)(бензотиен-2-ил)метилен] пиперидин-1-илметил] бензоил] пиперидина, малеата,
1-[3-[4-[(4-фторфенил)(бензотиен-2-ил)метилен] пиперидин-1-илметил] бензоил] пирролидина, малеата,
1-[3-[4-[(4-фторфенил)(4-этилтиен-2-ил)метилен] пиперидин-1-илметил] бензоил] пиперидина, фумарата,
1-[3-[4-[(4-фторфенил)(4-этилтиен-2-ил)метилен] пиперидин-1-илметил] бензоил] пирролидина, дигидрохлорида,
4,4-диметил-1-[3-[4-[(4-фторфенил)(4-метилтиен-2-ил)метилен] пиперидин-1-илметил] бензоил] азетидина, малеата,
и их фармацевтически приемлемые соли и сольваты.7. The compound according to any one of paragraphs. 1-5, selected from:
1- [4- [4 - [(4-fluorophenyl) (4-methylthien-2-yl) methylene] piperidin-1-yl] -1-oxobutyl] piperidine (1: 1) ethanedicarboxylate,
1- [4- [4 - [(4-fluorophenyl) (4-methylthien-2-yl) methylene] piperidin-1-yl] -1-oxobutyl] pyrrolidine, dihydrochloride,
1- [4- [4 - [(3-fluorophenyl) (4-methylthien-2-yl) methylene] piperidin-1-yl] -1-oxobutyl] piperidine, hydrochloride,
1- [3- [4 - [(4-fluorophenyl) (4-methylthien-2-yl) methylene] piperidin-1-ylmethyl] benzoyl] piperidine,
1- [3- [4 - [(4-fluorophenyl) (4-methylthien-2-yl) methylene] piperidin-1-ylmethyl] benzoyl] pyrrolidine hydrochloride,
1- [3- [4 - [(4-fluorophenyl) (benzothien-2-yl) methylene] piperidin-1-ylmethyl] benzoyl] piperidine, maleate,
1- [3- [4 - [(4-fluorophenyl) (benzothien-2-yl) methylene] piperidin-1-ylmethyl] benzoyl] pyrrolidine, maleate,
1- [3- [4 - [(4-fluorophenyl) (4-ethylthien-2-yl) methylene] piperidin-1-ylmethyl] benzoyl] piperidine, fumarate,
1- [3- [4 - [(4-fluorophenyl) (4-ethylthien-2-yl) methylene] piperidin-1-ylmethyl] benzoyl] pyrrolidine, dihydrochloride,
4,4-dimethyl-1- [3- [4 - [(4-fluorophenyl) (4-methylthien-2-yl) methylene] piperidin-1-ylmethyl] benzoyl] azetidine, maleate,
and their pharmaceutically acceptable salts and solvates.
(А) взаимодействие соединения формулы II
где R1 и R2 имеют значения, определенные в п. 1 с соединением формулы R3-L, где L обозначает подходящую отщепляемую группу,
(В) взаимодействие амина формулы III
где R1, R2 и R6 имеют значения, определенные в п. 1 с подходящим ацилирующим агентом и, после этого или одновременно с этим, выполнение одного или нескольких из следующих необязательных превращений:
(i) превращение фармацевтически приемлемых соли или сольвата соединения формулы (I) в соединение формулы (I);
(ii) превращение фармацевтически приемлемых соли или сольвата соединения формулы (I) в другие фармацевтически приемлемые соль или сольват соединения формулы (I);
(iii) превращения соединения формулы (I) в фармацевтически приемлемые соль или сольват соединения формулы (I).10. The method of obtaining the compounds of formula (I) according to any one of paragraphs. 1-7, including
(A) the interaction of the compounds of formula II
where R 1 and R 2 are as defined in claim 1 with a compound of the formula R 3 -L, where L is a suitable leaving group,
(B) the interaction of the amine of the formula III
where R 1 , R 2 and R 6 have the meanings defined in paragraph 1 with a suitable acylating agent and, after that or at the same time, performing one or more of the following optional transformations:
(i) converting a pharmaceutically acceptable salt or solvate of the compound of formula (I) into a compound of formula (I);
(ii) converting a pharmaceutically acceptable salt or solvate of the compound of formula (I) into other pharmaceutically acceptable salt or solvate of the compound of formula (I);
(iii) converting a compound of formula (I) into a pharmaceutically acceptable salt or solvate of a compound of formula (I).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97203107 | 1997-10-07 | ||
EP97203107.4 | 1997-10-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2000111489A true RU2000111489A (en) | 2002-05-10 |
RU2198172C2 RU2198172C2 (en) | 2003-02-10 |
Family
ID=8228799
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2000111489/04A RU2198172C2 (en) | 1997-10-07 | 1998-10-07 | Substituted piperidine derivatives and pharmaceutical composition |
Country Status (16)
Country | Link |
---|---|
US (4) | US6365604B1 (en) |
EP (1) | EP1021440A2 (en) |
JP (1) | JP2001519430A (en) |
KR (1) | KR20010024441A (en) |
CN (1) | CN1274357A (en) |
AU (1) | AU747393B2 (en) |
BR (1) | BR9812862A (en) |
CA (1) | CA2305277A1 (en) |
HU (1) | HUP0004796A3 (en) |
IL (1) | IL135195A0 (en) |
NO (1) | NO20001778L (en) |
NZ (1) | NZ503711A (en) |
PL (1) | PL340294A1 (en) |
RU (1) | RU2198172C2 (en) |
TR (1) | TR200000916T2 (en) |
WO (1) | WO1999019324A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6770659B2 (en) * | 2002-08-26 | 2004-08-03 | Sk Corporation | Benzoyl piperidine compounds |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL88063C (en) * | 1950-12-05 | |||
US4640925A (en) * | 1983-06-02 | 1987-02-03 | Warner-Lambert Company | Diphenylmethylene piperidines, compositions and use |
US4540780A (en) * | 1983-06-02 | 1985-09-10 | Warner-Lambert Company | Diphenylmethylene piperidines |
NO912475L (en) | 1990-06-27 | 1991-12-30 | Sankyo Co | TIAZOLIDINE CARBOXYLIC ACID AMIDE DERIVATIVES WITH ANTIALLERGIC ACTIVITY AND PROCEDURE FOR PREPARING THEREOF. |
IL118768A (en) * | 1995-07-12 | 2000-10-31 | Akzo Nobel Nv | Diphenylmethane piperidine derivatives pharmaceutical compositions containing them and a method for their preparation |
-
1998
- 1998-10-07 RU RU2000111489/04A patent/RU2198172C2/en not_active IP Right Cessation
- 1998-10-07 TR TR2000/00916T patent/TR200000916T2/en unknown
- 1998-10-07 WO PCT/EP1998/006521 patent/WO1999019324A2/en not_active Application Discontinuation
- 1998-10-07 BR BR9812862-0A patent/BR9812862A/en not_active IP Right Cessation
- 1998-10-07 JP JP2000515896A patent/JP2001519430A/en not_active Withdrawn
- 1998-10-07 US US09/529,204 patent/US6365604B1/en not_active Expired - Fee Related
- 1998-10-07 AU AU21506/99A patent/AU747393B2/en not_active Ceased
- 1998-10-07 IL IL13519598A patent/IL135195A0/en unknown
- 1998-10-07 PL PL98340294A patent/PL340294A1/en not_active Application Discontinuation
- 1998-10-07 NZ NZ503711A patent/NZ503711A/en unknown
- 1998-10-07 CN CN98809976A patent/CN1274357A/en active Pending
- 1998-10-07 CA CA002305277A patent/CA2305277A1/en not_active Abandoned
- 1998-10-07 HU HU0004796A patent/HUP0004796A3/en unknown
- 1998-10-07 EP EP98965629A patent/EP1021440A2/en not_active Withdrawn
- 1998-10-07 KR KR1020007003722A patent/KR20010024441A/en not_active Application Discontinuation
-
2000
- 2000-04-06 NO NO20001778A patent/NO20001778L/en not_active Application Discontinuation
-
2002
- 2002-01-11 US US10/045,726 patent/US20020087001A1/en not_active Abandoned
- 2002-04-25 US US10/131,867 patent/US20020165395A1/en not_active Abandoned
-
2003
- 2003-01-28 US US10/353,131 patent/US20030149269A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2000129161A (en) | DERIVATIVE 1 - [(1-SUBSTITUTED-4-PIPERIDINYL) METHYL] -4-PIPERIDINE, METHOD FOR ITS PRODUCTION, PHARMACEUTICAL COMPOSITION CONTAINING THE INDICATED COMPOUND, AND THE INTERMEDIATE PRODUCT | |
RU2214400C2 (en) | Derivatives of 1-[(1-substituted-4-piperidinyl)- methyl]-4-piperidine, methods for their preparing, pharmaceutical composition based on thereof and intermediate substances | |
RU2475487C2 (en) | Imidazochinolines with immunomodulating properties | |
JP2003506406A5 (en) | ||
JP2010504930A5 (en) | ||
PE20021089A1 (en) | TRIAZOLE COMPOUNDS AS CYTOKINE INHIBITORS | |
RU2007119373A (en) | PHARMACEUTICAL COMPOUNDS | |
RU2005114489A (en) | N-Acryl-4-methylene-3-hydroxy-2-pyridones as antimicrobial agents | |
JP2006514942A5 (en) | ||
DE60208568D1 (en) | PROSTAGLANDINANALOGA AS EP4 RECEPTOR AGONISTS | |
RU2010138577A (en) | HEMOKIN CxCR3 RECEPTOR INHIBITORS | |
EP1419773A3 (en) | 4-Phenylpiperidine derivatives as modulators of dopamine neurotransmission | |
MEP12608A (en) | Derivatives of n-[phenyl (pyrrolidine-2-yl) methyl]benzamide and n-[(azepan-2-yl)phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics | |
ATE297381T1 (en) | ETHER MUSCARIAN ANTAGONISTS | |
CA2569861A1 (en) | Pyrrolidine derivatives as ccr5 antagonists | |
RU2005111968A (en) | 4-pyrrolidinophenylbenzyl ether derivatives | |
YU2290A (en) | Process for piperidine obtaining | |
FR2844270B1 (en) | QUINOLYL PROPYL PIPERIDINE DERIVATIVES, THEIR PROCESS AND PREPARATION INTERMEDIATES AND THE COMPOSITIONS CONTAINING THEM | |
RU94034117A (en) | Azole derivatives, methods of their synthesis and antifungal agent | |
RU96107125A (en) | DERIVATIVE BENZAZEPINA, PHARMACEUTICAL COMPOSITION ON ITS BASIS AND INTERMEDIATE PRODUCT | |
NZ333513A (en) | 1,4-di-substituted piperidines and medicaments useful as muscarinic antagonists | |
KR930004262A (en) | Metanoanthracene compounds | |
KR900014408A (en) | Novel 1H, 3H-pyrrolo [1,2-C] thiazole-7-carboxamide derivatives, preparations thereof and pharmaceutical compositions containing said derivatives | |
HUP0302961A2 (en) | Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same | |
RU2001121084A (en) | New derivatives of N-triazolylmethylpiperazine as antagonists of neurokinin receptors |